Skip to main content
NIH funding notice RFA-DA-21-004

Exploring the Roles of Biomolecular Condensates (BMCs) in HIV replication, latency, or pathogenesis in the context of substance use disorders (R21/R33 Clinical Trial Not Allowed)

Closed on July 20, 2020.

Posted
February 24, 2020
Close date
July 20, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $409,453 in first-year total cost, median $204,727.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 TXT-V (10)]2

Most frequent institutions

  1. PENNSYLVANIA STATE UNIV HERSHEY MED CTR1
  2. STATE UNIVERSITY NEW YORK STONY BROOK1
Competing awards under RFA-DA-21-004 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Characterizing the physicochemical properties of membraneless condensates and its regulation by delta-9-tetrahydrocannabinol in HIV/SIV infection.1R21DA053643-01MOHAN, MAHESHOKEOMA, CHIOMA MSTATE UNIVERSITY NEW YORK STONY BROOK, NY$221,093ZDA1
2021Role of biomolecular condensates in regulating HIV-1 viral ribonucleoprotein complex formation in the setting of substance use disorder1R21DA053689-01PARENT, LESLIE JPENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA$188,360ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.